SSi Mantra

Multi-specialty teleoperated surgical robotic system covering general, urological, colorectal, gynecological, and cardiac surgery. Commercially deployed internationally with 510(k) pending for U.S. market entry.

Yes. SSi Mantra is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

SSi Mantra is made by SS Innovations International, based in United States.

6 verified deployments of SSi Mantra are on the DEPLOY registry, including at India, Continental Hospital, Apex Hospital.

SSi Mantra is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

SSi Mantra has 2 regulatory records on the DEPLOY registry: FDA 510(k) clearance, pending; FDA 510(k) clearance, pending. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable surgical robots to SSi Mantra include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

SSi Mantra and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. SSi Mantra has 6 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, SSi Mantra ranks in roughly the top 27% of surgical models tracked by the registry.

SSi Mantra is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

SSi Mantra has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.